Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Plos Currents|March 30, 2012
Percent-predicted 6-minute walk distance in duchenne muscular dystrophy to account for maturational influencesErik Henricson, Richard Abresch, Jay J Han, et al.Orphanet Journal of Rare Diseases|July 23, 2020
Wound closure in epidermolysis bullosa: data from the vehicle arm of the phase 3 ESSENCE StudyDedee F Murrell, Amy S Paller, Christine Bodemer, et al.Orphanet Journal of Rare Diseases|June 25, 2020
Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)Amy S Paller, John Browning, Milos Nikolic, et al.Orphanet Journal of Rare Diseases|January 5, 2020
The challenges of living with and managing epidermolysis bullosa: insights from patients and caregiversAnna L Bruckner, Michael Losow, Jayson Wisk, et al.Muscle & Nerve|November 2, 2010
The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observationsCraig M McDonald, Erik K Henricson, Jay J Han, et al.Muscle & Nerve|March 14, 2013
Corticosteroids in Duchenne muscular dystrophy: major variations in practiceRobert C Griggs, Barbara E Herr, Allen Reha, et al.Muscle & Nerve|November 27, 2009
The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophyCraig M McDonald, Erik K Henricson, Jay J Han, et al.Plos One|December 19, 2013
Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophyRichard S Finkel, Kevin M Flanigan, Brenda Wong, et al.Muscle & Nerve|May 16, 2013
The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter studyCraig M McDonald, Erik K Henricson, R Ted Abresch, et al.Muscle & Nerve|May 18, 2013
The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter studyCraig M McDonald, Erik K Henricson, R Ted Abresch, et al.Pageof 2